Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report)’s share price rose 2.1% on Thursday . The stock traded as high as $3.6380 and last traded at $3.6165. Approximately 27,062 shares changed hands during mid-day trading, an increase of 100% from the average daily volume of 13,527 shares. The stock had previously closed at $3.5430.
Medexus Pharmaceuticals Price Performance
The business has a 50-day moving average of $3.64 and a 200-day moving average of $3.08.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
Further Reading
- Five stocks we like better than Medexus Pharmaceuticals
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
